BNTX Reports Encouraging Pumitamig Trial Data: 57.1% cORR in Non-Squamous NSCLC, 68.4% in Squamous NSCLC, Manageable Safety Profile
BioNTech SE American Depositary Share · Now $95.95
-0.1% in 1h after detection
Post-detection moves
1h
-0.1%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS